Filing Details
- Accession Number:
- 0000899243-22-014360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-08 16:34:51
- Reporting Period:
- 2022-04-07
- Accepted Time:
- 2022-04-08 16:34:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-04-07 | 204 | $275.71 | 43,139 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-07 | 327 | $276.39 | 42,812 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-07 | 30 | $277.02 | 42,782 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1.
- Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $275.71 (range $275.00 to $275.95).
- Open market sales reported on this line occurred at a weighted average price of $276.39 (range $276.00 to $276.78).
Billionaire Hedge Funds
